AFAimé Gabriel Fankam

Aimé Gabriel Fankam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aimé Gabriel Fankam has a total of 140 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ethnopharmacological study, evaluation of antimicrobial and free radical scavenging activities of extracts from plants used in the management of dental caries: a comparative study

    by Remi Ridha Nsatar, Michel Noubom, Irene Memeh Tumanjong, Marie Stephanie Chekem Goka, Aimé Gabriel Fankam, Gael Marius Tsaffo, Gabriel Kamsu Tchuente, Aurelie Dahlia Piankeu Yemeli, Donatien Gatsing

    Dental caries is a highly prevalent and costly biofilm-dependent disease that affects about 2.3 billion people in their permanent teeth and 532&am

  • Open Access

    Antibacterial and antibiotic resistance modulation potentials of Nephelium lappaceum (Sapindaceae) against multidrug-resistant Pseudomonas aeruginosa

    by Jason B.T. Kuete, Aimé G. Fankam, Roland T. Tchuenguem, Ivana N. Ngounou, Sorelle R.Y. Sofeu, Anastasie G.A. Andela, Jenifer R.N. Kuete, Prosper E.K. Lele, Eric Cadet, Michael F. Kengne, et al.

    • 2 March 2026
      • Vol. 2026, 6070077
    Open Access

    Phytochemical Composition and Antipseudomonal Activity of Allanblackia gabonensis (Clusiaceae) Extracts Alone and With Antibiotics Against Drug‐Resistant Clinical Isolates

    by Céline Brinda Sonfack, Aimé Gabriel Fankam, Brenda Ngueffo Tiwa, Michael Francis Kengne, Armelle Tsafack Mbaveng, Victor Kuete

    The discovery of alternative therapies for illnesses due to multidrug‐resistant (MDR) bacteria is emerging as a global health crisis. This study aimed to assess the antibacterial efficacy of Allanblackia gabonensis extracts, both alone and in conjunction with antibiotics, against MDR Pseudomonas aeruginosa. The extracts were subjected to phytochemical analysis using both qualitative and quantitative standard tests. The microdilution assay was used to evaluate the antibacterial properties and antibiotic resistance‐modifying potential of the extracts. The interaction effect between the antibiotics and extracts was determined by checkerboard assay. Catalase activity and lipid peroxidation were assessed by measuring the foam height and malondialdehyde concentration, respectively. The extracts exhibited minimum inhibitory concentrations (MICs) ranging from 16 to 2048 μg/mL. The hexane extracts of the leaves (HLE) and bark (HBE) displayed the highest antibacterial activity, with MIC ≤ 32 μg/mL against at least two investigated isolates. Furthermore, HLE decreased catalase activity and increased lipid peroxidation in P. aeruginosa D130. The extracts at their sub‐inhibitory concentration (MIC/8) enhanced the activity of antibiotics, mainly aminoglycosides (amikacin, streptomycin, and gentamicin), by 2‐ to 256‐fold against selected MDR P. aeruginosa. Among these extracts, the hexane and methanol bark extracts exhibited synergy (∑FIC ≤ 0.5)) in combination with these antibiotics. All examined extracts contained alkaloids, phenols, and triterpenes. Moreover, dichloromethane/methanol and methanol leaf extracts presented the highest phenolic content. Overall, the leaf and bark hexane extracts of A. gabonensis could serve as candidates for the discovery of new antibiotics, while its bark extracts might be used in conjunction with antibiotics to manage infections involving multidrug‐resistant P. aeruginosa.

  • Open Access

    Anti-Pseudomonal Activity, Antibiotic Resistance Modulation Potential, and Effect of Dichloromethane/Methanol Extract of Imperata cylindrica (Gramineae) on the Antioxidant System of Multidrug-Resistant Pseudomonas aeruginosa

    by Aimé Gabriel Fankam, Céline Brinda Sonfack, Brenda Ngueffo Tiwa, Victor Kuete

    Objectives: Infections caused by multidrug-resistant (MDR) Pseudomonas aeruginosa are a significant public health concern. Imperata cylindrica is a dietary plant used in traditional medicine to treat many health conditions, including microbial infections. This study aimed to evaluate the anti-pseudomonal activity, antibiotic resistance modulation potential, and the effect of dichloromethane/methanol extract of I . cylindrica rhizomes on the antioxidant system of MDR P. aeruginosa . Methods: The microdilution method was used to assess the anti-pseudomonal and antibiotic resistance modulation activities of the extract. The effect of the extract on catalase activity and lipid peroxidation was evaluated by measuring the height of the foam and spectrophotometric quantification of malondialdehyde, respectively. Results: The tested extract displayed variable antibacterial activity, with minimum inhibitory concentrations (MICs) ranging from 32 to 2048 µg/mL. Higher anti-pseudomonal activity was observed against P. aeruginosa D130 (MIC = 32 µg/mL) and K290 (MIC = 64 µg/mL). At its sub-inhibitory concentration (MIC/8), I. cylindrica extract enhanced the activity of the tested antibiotics, mainly aminoglycosides (streptomycin, amikacin, and gentamycin), by 2 to 258-fold. The extract also affected the antioxidant system of P. aeruginosa D130, by inhibiting catalase activity, as confirmed by lipid peroxidation. Conclusion: These findings indicate that the dichloromethane/methanol extract of Imperata cylindrica rhizomes can serve as a potential candidate for the discovery of new antibiotics or antibiotic-resistant modulators to efficiently treat infections involving MDR Pseudomonas aeruginosa .

  • Open Access

    Talinum fruticosum (L.) Juss. (Talinaceae), an Edible and Medicinal Plant, Enhances the Activity of Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria

    by Aimé Fankam, Varelle Diffo, Richard Mouozong, Valaire Matieta, Fabrice Megaptche, Victor Kuete

    The rapid acquisition of multidrug-resistant (MDR) phenotypes by bacteria creates life-threatening complications in infection control. Accordingly, this study aims to investigate the antibacterial activity of the methanol extract of Talinum fruticosum leaves and its interaction effects with antibiotics against MDR Gram-negative bacteria . The broth microdilution method was used to evaluate the antibacterial activity and antibiotic-resistance modulation effects of the extract. The interaction between antibiotics and T. fruticosum leaf extract (TFLE) was conducted using the checkerboard assay. Phytochemical screening was assessed using standardized qualitative tests. TFLE displayed low antibacterial activity, with MICs ranging from 512 to 2048 µg/mL against the tested bacteria. Interestingly, TFLE at its subinhibitory concentration (MIC/8) enhanced the efficacy of antibiotics by 2-to 64-fold, particularly tetracycline, doxycycline, imipenem, kanamycin, and ciprofloxacin, against at least one of the examined MDR bacteria. In addition, TFLE displayed a synergistic effect (ƩFIC < 0.5) with kanamycin and doxycycline against K. pneumoniae K2 and E. aerogenes EA298. The phytochemical screening indicated that TFLE contained flavonoids, saponins, tannins, terpenoids, phenols, and anthocyanins. Overall, this study shows that T. fruticosum leaf extract could be used in combination with commonly used antibiotics to fight infections involving MDR bacteria. Therefore, further studies are needed to identify in this plant a likely nontoxic antibiotic modulator.

  • Evaluation of anti-staphylococcal activity and acute toxicity of hexane extracts of Macaranga occidentalis (Mull. Arg.) Mull. Arg (Euphobiaceae)

    by Prosper E. K. Lele, Soreille R. Y. Sofeu, Aimé G. Fankam, Jason B. T. Kuete, Remi R. Nsatar, Victor Kuete

    Background: Macaranga occidentalis is well known in traditional medicine for the treatment of various ailments like bruises, boils, cuts, sores, and diarrhea. This study aimed to investigate in vitro and in vivo the anti-staphylococcal activity of Macaranga occidentalis extracts on selected Staphylococcus aureus, including multidrug resistance (MDR) isolates. Moreover, the acute toxicity of the active extract was assessed. Methods: Extracts were prepared by maceration of M. occidentalis in hexane. The in vitro activity of the extracts was determined using the broth microdilution method. The in vivo anti-staphylococcal activity and acute toxicity of the hexane extract were assessed in Wistar rats. Results: The hexane leaves and bark extracts of M. occidentalis demonstrated antibacterial activity, with minimum inhibitory concentrations (MIC) ranging from 64 to 2048 μg/mL. In vivo, the hexane leaf extract (the most active) significantly reduced the bacterial load in S. aureus D021-infected Wistar rats after the tenth day of the experiment. It showed no toxic effect on blood cells and even enhanced hemoglobin production. Furthermore, at a dose of 5000 mg/kg body weight, this extract showed no signs of toxicity in rats, indicating that the median lethal dose (LD50) is greater than 5000 mg/kg body weight. Conclusion: Macaranga occidentalis extracts, especially its leaf hexane extract, constitute promising alternative therapeutic sources for infections caused by MDR Staphylococcus aureus. Therefore, further studies including its subacute and chronic toxicity, as well as the identification of its active ingredients, should be envisaged.

  • Open Access

    Phytochemical Composition and Antipseudomonal Activity of Allanblackia gabonensis (Clusiaceae) Extracts Alone and With Antibiotics Against Drug‐Resistant Clinical Isolates

    by Céline Brinda Sonfack, Aimé Gabriel Fankam, Brenda Ngueffo Tiwa, Michael Francis Kengne, Armelle Tsafack Mbaveng, Victor Kuete

    Background: The discovery of alternative therapies for illnesses due to multidrug‐resistant (MDR) bacteria is emerging as a global health crisis. This study aimed to assess the antibacterial efficacy of Allanblackia gabonensis extracts, both alone and in conjunction with antibiotics, against MDR Pseudomonas aeruginosa . Methods: The extracts were subjected to phytochemical analysis using both qualitative and quantitative standard tests. The microdilution assay was used to evaluate the antibacterial properties and antibiotic resistance‐modifying potential of the extracts. The interaction effect between the antibiotics and extracts was determined by checkerboard assay. Catalase activity and lipid peroxidation were assessed by measuring the foam height and malondialdehyde concentration, respectively. Results: The extracts exhibited minimum inhibitory concentrations (MICs) ranging from 16 to 2048 μg/mL. The hexane extracts of the leaves (HLE) and bark (HBE) displayed the highest antibacterial activity, with MIC ≤ 32 μg/mL against at least two investigated isolates. Furthermore, HLE decreased catalase activity and increased lipid peroxidation in P. aeruginosa D130. The extracts at their sub‐inhibitory concentration (MIC/8) enhanced the activity of antibiotics, mainly aminoglycosides (amikacin, streptomycin, and gentamicin), by 2‐ to 256‐fold against selected MDR P. aeruginosa . Among these extracts, the hexane and methanol bark extracts exhibited synergy (∑FIC ≤ 0.5)) in combination with these antibiotics. All examined extracts contained alkaloids, phenols, and triterpenes. Moreover, dichloromethane/methanol and methanol leaf extracts presented the highest phenolic content. Conclusion: Overall, the leaf and bark hexane extracts of A. gabonensis could serve as candidates for the discovery of new antibiotics, while its bark extracts might be used in conjunction with antibiotics to manage infections involving multidrug‐resistant P. aeruginosa .

  • Ethnopharmacology, phytochemistry and pharmacological potential of the genus Diospyros

    by Aimé G. Fankam, Vaderament-A. Nchiozem-Ngnitedem, Armel J. Seukep, Gabin T.M. Bitchagno, Victor Kuete


  • Open Access

    Anti-staphylococcal activity, antibiotic-resistance modulation effects and action of Harungana madagascariensis (Hypericaceae) fruit extracts on the antioxidant system of multidrug-resistant Staphylococcus aureus

    by Brenda Ngueffo Tiwa, Aimé Gabriel Fankam, Céline Brinda Sonfack, Richard Mouozong, Michael Francis Kengne, Armelle Tsafack Mbaveng, Victor Kuete

    Global public health is facing a real challenge due to infections caused by multidrug-resistant bacteria. Among these bacteria, Staphylococcus aureus is known to rapidly develops antibiotic resistance. This study aimed to evaluate the antibacterial potential of Harungana madagascariensis fruit extracts and their effects on the antioxidant system of multidrug-resistant Staphylococcus aureus. Moreover, the extracts were evaluated for their antibiotic-resistance modulation effects against some multidrug-resistant Staphylococcus aureus. The antibacterial activity of the extracts and their effect in combination with antibiotics were assessed using the micro-dilution method. The catalase activity was assessed by measuring the height of foam, whereas the lipid peroxidation was carried out through spectrophotometric quantification of malondialdehyde. The phytochemical analysis of extracts was carried out using qualitative and quantitative standard assays. The tested extracts showed antibacterial activities, with minimum inhibitory concentrations ranging from 32 to 2048 μg/mL. The most active extract (hexane extract) has inhibited the catalase activity and induced the lipid peroxidation in S. aureus DO18SA, indicating its ability to interact with the antioxidant system of the bacteria. Moreover, the dichloromethane/methanol extract increased by 2–128-fold the activity of levofloxacin, ampicillin, and cefotaxime against selected multidrug-resistant S. aureus. It also showed synergistic effect with cefotaxime against D051SA. Alkaloids, triterpenes, and phenols were detected in all the extracts, whereas the other phytochemical classes were selectively distributed. The methanol extract had the highest phenolic content (142.20 ± 16.75 mg GAE/g of extract). Overall, the findings of this study suggest that extracts of Harungana madagascariensis fruits could be valuable sources of new agents for treating multidrug-resistant Staphylococcus aureus infections.


  • Open Access

    Phytochemical Composition, Antibacterial Activity, Modes of Action, and Antibiotic Resistance–Modifying Effects of Harungana madagascariensis (Hypericaceae) Against Multidrug‐Resistant Pseudomonas aeruginosa

    by Richard Mouozong, Aimé Gabriel Fankam, Varelle Lambou Diffo, Victor Kuete

    Harungana madagascariensis is a plant used in African traditional medicine to treat a wide range of human diseases, including microbial infections. The aim of this study was to evaluate the phytochemical composition, antibacterial activity, modes of action, and antibiotic resistance‐modifying effects of the leaf, bark and root extracts of H . madagascariensis against multidrug‐resistant Pseudomonas aeruginosa . The broth microdilution method was used to evaluate the antibacterial activity and antibiotic resistance–modifying effects of extracts. Phytochemical composition of extracts was carried out using known qualitative and quantitative methods. The action of the most active extract was evaluated on the bacteria cell membrane and catalase activity. The phytochemical results indicated that all the extracts contain alkaloids, terpenoids, saponins, phenols, flavonoids, tannins, and anthocyanins. Moreover, H . madagascariensis leaf extract (HMLE) had the highest phenolic (107.41 ± 9.66 mg GAE/g of extract) and flavonoid (53.67 ± 5.09 mg QE/g of extract) contents. The extracts had a wide range of antibacterial activity, with MICs ranging from 16 to 2048 μg/mL. HMLE identified as the most active extract affected the cytoplasmic membrane integrity and inhibited the catalase activity of P . aeruginosa . Moreover, HMLE at its subinhibitory concentration (MIC/8) improved the antibiotic activity by 2‐ to 16‐fold. The MICs of tetracycline and doxycycline deceased from 32 to ≤ 2 μ g/mL and that of kanamycin from 256 to 32 μg/mL against the tested MDR P . aeruginosa . In conclusion, this study indicates that extracts from H. madagascariensis , particularly from its leaves, could serve as valuable assets in the discovery of new treatment option of infections due to MDR P . aeruginosa .